Clinical Trials Directory

Trials / Unknown

UnknownNCT01402726

Renal Sympathetic Modification in Patients With Heart Failure

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
The Second Affiliated Hospital of Chongqing Medical University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to observe the incident of composite cardiovascular events after renal sympathetic modification using THERMOCOOL® catheter in patients with heart failure, and evaluate safety and efficacy of the intervention.

Detailed description

Heart failure is a clinical syndrome of chronic cardiac dysfunction, with high morbidity and mortality. Traditional pharmacological therapies are used in clinical practice without breakthrough for long time. Previous studies confirmed that partly blocking sympathetic nerves activity contributed to improve cardiac function in patients with heart failure. Renal ablation with sympathetic modification is a new method which is proved to be effective in decreasing sympathetic nerves activity. The investigators hypothesis that renal sympathetic nerves modification is effective and safe in improving cardiac function. This trial is going to recruit 200 patients (Ablation group VS Control group = 1:1) with a follow-up duration of 3 years. Patients in ablation group will receive additional necessary anti-heart failure drugs besides expectant intervention, and patients in control group will receive appropriate anti-heart failure drugs only. The investigators aim to observe the incident of composite cardiovascular events after renal sympathetic modification using THERMOCOOL® catheter in patients with heart failure, and evaluate safety and efficacy of the intervention.

Conditions

Interventions

TypeNameDescription
PROCEDURErenal sympathetic modificationDevice: THERMOCOOL® Catheter Renal sympathetic modification with a catheter-based procedure

Timeline

Start date
2011-07-01
Primary completion
2019-12-01
Completion
2020-06-01
First posted
2011-07-26
Last updated
2019-03-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01402726. Inclusion in this directory is not an endorsement.